CIDP - Chronic Inflammatory Demyelinating Polyneuropathy

Neurology·MeSH: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

Prevalence

5.0 / 100K

0 drugs in development·0 companies·2 clinical trials

Frequently asked questions

How many clinical trials target CIDP - Chronic Inflammatory Demyelinating Polyneuropathy?

There are 2 clinical trials targeting CIDP - Chronic Inflammatory Demyelinating Polyneuropathy tracked by BioSniper.

What is the prevalence of CIDP - Chronic Inflammatory Demyelinating Polyneuropathy?

The estimated prevalence of CIDP - Chronic Inflammatory Demyelinating Polyneuropathy is approximately 5.0 per 100,000 population.

Deep-dive into CIDP - Chronic Inflammatory Demyelinating Polyneuropathy

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    CIDP - Chronic Inflammatory Demyelinating Polyneuropathy — Drugs in Development & Clinical Trials | BioSniper